Home › Funds › SR ONE CAPITAL MANAGEMENT, LP › ZBIO

SR ONE CAPITAL MANAGEMENT, LP position in ZBIO

ZENAS BIOPHARMA INC COM · Health Care

SR ONE CAPITAL MANAGEMENT, LP reported holding 5,037,854 shares of ZBIO (ZENAS BIOPHARMA INC COM) in its Q2 2026 13F filing — a position valued at US$127.9M, representing 12.31% of its reported portfolio and ranking #2 among its reported holdings. SR ONE CAPITAL MANAGEMENT, LP has disclosed ZBIO holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)5.04M sh
Reported value held$127.86M
Portfolio Weight12.31%
First reportedQ3 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SR ONE CAPITAL MANAGEMENT, LP's ZBIO position evolved

SR ONE CAPITAL MANAGEMENT, LP first disclosed a stake in ZBIO in Q3 2024 at 4,911,539 shares (US$83.1M). The position peaked in Q4 2025 at 5,037,854 shares, worth US$182.9M. Across 8 filings, SR ONE CAPITAL MANAGEMENT, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 5,037,854 shares valued at US$127.9M.

Quarter by quarter

QuarterSharesValueChange
Q3 2024 4.91M $83.10M New
Q4 2024 4.91M $40.23M Hold
Q1 2025 4.91M $38.80M Hold
Q2 2025 4.91M $47.59M Hold
Q3 2025 4.91M $109.04M Hold
Q4 2025 5.04M $182.92M Add
Q1 2026 5.04M $98.49M Hold
Q2 2026 5.04M $127.86M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZBIO and 13F data

ZBIO (ZENAS BIOPHARMA INC COM) is a Health Care company. 68 other funds we track also report a position in ZBIO — the largest reported positions include NEA Management Company, LLC (US$102.1M), Enavate Sciences GP, LLC (US$99.5M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$80.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZBIO

All ZBIO fund holders →

FAQ

How long has SR ONE CAPITAL MANAGEMENT, LP held ZBIO?

SR ONE CAPITAL MANAGEMENT, LP has disclosed ZBIO holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is SR ONE CAPITAL MANAGEMENT, LP's current position in ZBIO?

As of Q2 2026, SR ONE CAPITAL MANAGEMENT, LP holds 5.04M shares of ZBIO (ZENAS BIOPHARMA INC COM), valued at $127.86M, representing 12.31% of its reported portfolio and ranking #2.

Has SR ONE CAPITAL MANAGEMENT, LP been buying or selling ZBIO?

In the latest 13F filing (Q2 2026), SR ONE CAPITAL MANAGEMENT, LP held unchanged its position in ZBIO. The position peaked in Q4 2025 at 5.04M shares.

Which other funds hold ZBIO?

Other major institutional holders of ZBIO include NEA Management Company, LLC, Enavate Sciences GP, LLC, DEERFIELD MANAGEMENT COMPANY, L.P., among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.